which glp-1 has least gi side effects Adverse of Glucagon-Like Peptide-1 Receptor Agonists TrimRX | GLP-1 vs GIP:
Description
Concerning sweet and salty tastes, clinical studies have yielded conflicting results
A notable development is the launch of Wegovy by Novo Nordisk A/S in March 2024, the first once-weekly GLP-1 therapy designed to manage weight effectively, showcasing a safe and convenient approach for patients
Some people whove experienced dramatic weight loss with GLP-1s like Ozempic and Wegovy say the effects are more noticeable on the tops of their feet, where tendons and veins are more prominent
Patients can self-inject subcutaneously in the abdomen, thigh, or upper arm, rotating injection sites to minimize local reactions
